Latest news with #OpeningNight
New York Post
4 days ago
- Entertainment
- New York Post
Billy Joel not attending Tribeca Film Festival doc premiere after brain disorder news
And so it goes, indeed. Billy Joel will not be attending the Tribeca Festival opening-night world premiere of his documentary 'And So It Goes' next Wednesday, The Post can exclusively reveal. The Piano Man will be sitting out on his big night after revealing that he was diagnosed with a brain disorder called normal pressure hydrocephalus. Advertisement 4 Billy Joel has canceled all of his upcoming tour dates. Getty Images 'Our hearts are with Billy Joel and his family following today's announcement,' Tribeca Festival co-founders Jane Rosenthal and Robert De Niro said in a statement on May 23. 'As a New York icon and global music legend, he has profoundly shaped the cultural fabric of this city and touched audiences around the world. We send our love and full support and wish him strength and a healthy recovery.' 'We're deeply honored that this year's Opening Night celebrates his remarkable legacy and enduring influence on New York's cultural landscape,' the statement continued. 'This is the perfect moment to recognize a creative force whose work reflects the very soul of our city—and the heart of Tribeca.' Advertisement Joel's brain disorder occurs when cerebrospinal fluid builds up inside the skull and presses on the brain, disrupting cognitive functioning. Due to his diagnosis, the 76-year-old music legend also canceled all of his upcoming tour dates. His team explained his condition became worse due to his recent concerts, which led 'to problems with hearing, vision and balance.' 4 Billy Joel ended his historic monthly residency at Madison Square Garden last July. Getty Images Advertisement 'Under his doctor's instructions, Billy is undergoing specific physical therapy and has been advised to refrain from performing during his recovery period,' the statement read last week. 'Billy is thankful for the excellent care he is receiving and is fully committed to prioritizing his health. He is grateful for the support from fans during this time and looks forward to the day when he can once again take the stage.' Joel added in his own statement: 'I'm sincerely sorry to disappoint our audience, and thank you for understanding.' But apparently, Joel isn't ready to retire. 4 Billy Joel performed at the 66th annual Grammy Awards in February 2024. AFP via Getty Images Advertisement 'He is happiest while performing,' a music industry insider told People on Tuesday. 'Music is, has been and will always be his life. He's not ready to retire.' On Monday, the artist's wife, Alexis Roderick Joel, whom he tied the knot with in a surprise ceremony in 2015, addressed fans on Joel's social media account. 'Thank you for the outpouring of love and support,' she wrote. 'We are so grateful for the wonderful care and swift diagnosis we received.' The pair share daughters Della, 9, and Remy, 7. 4 'Thank you for the outpouring of love and support,' Alexis Roderick Joel wrote on her husband's Instagram. billyjoel/Instagram Joel's ex-wife, Christie Brinkley, and their daughter, Alexa Ray Joel, have also publicly supported him. 'Dear Billy, The whole Brinkley gang is sending you lots of love and good wishes for a full and speedy recovery,' Brinkley, 71, wrote via Instagram on Saturday. 'I was looking for some cute photos of you and Alexa to send you, when I came across this clip from a recent concert. It made me laugh … but it also reminded me of all the joy you create, and all the sensational singalongs you've led.' Alexa, 39, for her part, shared: 'We love you and we got you, Pop! I just wanted to thank you all for the beautiful outpouring of love and support amid the recent news of My Father's health diagnosis. My Dad is the strongest and most resilient man I've ever known … and he's entirely committed to making a full recovery with ongoing physical-therapy treatments as he continues to regain his strength.'
Yahoo
25-05-2025
- Sport
- Yahoo
Just how different will the Boston Celtics roster be next season?
Just how different will the Boston Celtics roster be next season? The Celtics are projected to make some moves this offseason to lessen the impact of their looming historic payroll and tax bill, set to check in at close to a half-billion dollars as currently constructed. But which players are most likely going to be playing for new teams (or no teams) for the NBA's 2025-26 regular season, and which might still be suiting up for Boston on Opening Night? With the injuries to the Celtics' star forwards Jayson Tatum and Jaylen Brown muddying up how the team's front office might be looking at the situation, there could be little change -- or quite a lot. Advertisement The folks behind the "WEEI Boston's Sports Original" YouTube channel put together a clip from their "Greg Hill" show to talk it over with guest Megan Ottolini. Take a look at the clip embedded below to hear what they had to say about how the team might look at the start of next season. This article originally appeared on Celtics Wire: Just how different will the Celtics roster be next season?
USA Today
25-05-2025
- Sport
- USA Today
Just how different will the Boston Celtics roster be next season?
Just how different will the Boston Celtics roster be next season? Just how different will the Boston Celtics roster be next season? The Celtics are projected to make some moves this offseason to lessen the impact of their looming historic payroll and tax bill, set to check in at close to a half-billion dollars as currently constructed. But which players are most likely going to be playing for new teams (or no teams) for the NBA's 2025-26 regular season, and which might still be suiting up for Boston on Opening Night? With the injuries to the Celtics' star forwards Jayson Tatum and Jaylen Brown muddying up how the team's front office might be looking at the situation, there could be little change -- or quite a lot. The folks behind the "WEEI Boston's Sports Original" YouTube channel put together a clip from their "Greg Hill" show to talk it over with guest Megan Ottolini. Take a look at the clip embedded below to hear what they had to say about how the team might look at the start of next season.
Yahoo
15-05-2025
- Sport
- Yahoo
Knicks' All-Star center not getting ahead of himself with Game 3 approaching
The New York Knicks have a chance to go up 3-0 in their second round playoff series against the Boston Celtics on Saturday. It can be easy for them to get complacent and think that they will be able to cruise the rest of the way. Knicks' Karl-Anthony Towns taking it one game at a time However, that is certainly not the case with this Celtics team, as they are the defending champions and can easily make this a series with a victory of their own. While their backs are against the wall, Boston can still come back in this series and take down New York. Credit: David Butler II-Imagn Images Therefore, the Knicks must keep their foot on the gas and apply pressure to bury the Celtics. Karl-Anthony Towns has a similar mindset and is not thinking about potentially being up 3-0 ahead of Game 3. Advertisement 'We haven't gotten a 3-0 lead, so let's take it game-by-game. We've got to continue playing Knicks basketball and let the chips fall where they fall,' Towns said via SNY. The Knicks still need to play better basketball The Knicks have won both games so far this series in dramatic comeback fashion, which can be demoralizing for Boston especially since both games were at home for them. However, New York's wins have been far from perfect, and they will need to clean up some things if they wish to gain full control. First and foremost, New York has to start games stronger. In Game 2, they only scored 13 first quarter points and found themselves down 20 late in the third quarter. Luckily for them, their defense has played up this series and has been a big reason for their success. Credit: David Butler II-Imagn Images However, they cannot afford to continue their slow starts against Boston, as they have the capability to outscore their opponents in bunches. This is the same Celtics team that made 29 three-pointers on Opening Night against this Knicks team, so New York knows very well what they are capable of. Game 3 is set to tip off at 3:30 P.M. EST Saturday.
Miami Herald
12-05-2025
- Business
- Miami Herald
ALT5 Sigma Sponsors Consensus 2025, Showcasing Crypto Infrastructure Built for Real-World Finance
ALT5 Sigma brings regulated rails and next-gen payment infrastructure to the biggest stage in crypto LAS VEGAS, NEVADA / ACCESS Newswire / May 9, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS)(FRA:5AR1), a fintech specializing in turnkey, crypto-related solutions for institutions and merchants, is pleased to announce its participation in Consensus 2025, taking place May 14-16, 2025, in Toronto, Canada. ALT5 Sigma will exhibit at Booth #2023 and is proud to be a sponsor of Opening Night, one of the premier events kicking off the week. Consensus 2025 is the most influential gathering for the crypto, blockchain, and Web3 ecosystem, bringing together institutional leaders, builders, developers, and policymakers from around the world. ALT5's infrastructure powers real-time stablecoin settlement, crypto payment processing, and digital asset rails for use cases ranging from cross-border merchant payments to API-driven fintech integrations and FX and trading desks seeking digital asset exposure. "As digital assets move beyond speculation, the real challenge is building the infrastructure that supports regulation, scale, and trust," said Peter Tassiopoulos, CEO of ALT5 Sigma. "ALT5 is focused on enabling that next phase: where financial institutions and fintechs can operate with confidence, compliance, and speed." Built for Scale, Designed for Compliance ALT5 delivers API-first, custody-ready infrastructure that enables real-time settlement, stablecoin-based payments, and digital asset capabilities at scale. Used by fintechs, payment processors, FX, and trading desks, and neobanks, ALT5's platform supports enterprise-grade integration, while aligning with evolving regulatory frameworks. Whether building new rails for programmable payments or navigating compliant access to digital assets, ALT5 helps bridge traditional finance with emerging digital systems-offering tools designed for institutional-grade deployment. Meet ALT5 Sigma at Consensus 2025 The ALT5 team, including executive leadership and product specialists, will be on-site for live demos, partner meetings, and ecosystem conversations throughout the event. To connect, please reach out to info@ or stop by Booth #2023 on the show floor. About ALT5 Sigma Corporation ALT5 Sigma Corporation (NASDAQ:ALTS)(FRA:5AR1) is a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing settlement, payment and safe keeping of digital assets. ALT5 has been a constituent of the Russell Microcap Index since June 28, 2024. Founded in 2018, ALT5 Sigma, Inc. (a wholly owned subsidiary of ALT5 Sigma Corporation) enables the migration to a new global financial paradigm through its suite of blockchain infrastructure technologies. ALT5 Sigma, Inc., through its subsidiaries, offers two main platforms: "ALT5 Pay" and "ALT5 Prime." The Company has processed over $5 billion USD in cryptocurrency transactions since inception. ALT5 Pay is an award-winning cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency(s) automatically or to receive their payment in digital assets. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers. The Company is also advancing the separation of its biotech business, which will continue under "Alyea Therapeutics Corporation." Through its biotech activities, the Company is focused on bringing to market drugs with non-addictive pain-relieving properties to treat conditions that cause chronic or severe pain. Our patented product, a novel formulation of low-dose naltrexone (JAN123), is being initially developed for the treatment of Complex Regional Pain Syndrome (CRPS), an indication that causes severe, chronic pain generally affecting the arms or legs. The FDA has granted Jan123 Orphan Drug Designation for treatment of CRPS. Forward Looking Statements This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5's platforms and business, that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion. This press release also may contain statements and links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as "continue", "expect", "intend", "will", "hope", "should", "would", "may", "potential", and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies. Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance, or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the sections entitled "Risk Factors" in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results, and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein. Media/Investor Relations Contact IR@ SOURCE: ALT5 Sigma Corp
